We hypothesize that the disruption of the FLNA—PTEN interaction in AD lymphocytes, and presumably also in brain, may impair PTEN’s negative regulation of the mTOR pathway, contributing to the overactive mTOR signaling in AD. Here, MTOR is linked to Alzheimer disease.